1. Rx watchdog report: brand name drug prices continue to climb despite low general inflation rate Publication: Washington, D.C. : AARP Public Policy Institute, c2010 Subject(s): Drug Costs -- trendsPrescription Drugs -- economicsDrugs, Generic -- economicsForecastingHealth Care Reform -- economicsInflation, EconomicMedicare Part D -- economicsPharmaceutical Preparations -- economicsHumansUnited States
